{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:58:36Z","timestamp":1787497116738,"version":"build-2736575974"},"reference-count":31,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2018,5,17]]},"abstract":"<jats:p>Endothelin-1 (ET-1) induces pulmonary vascular remodeling and pulmonary hypertension secondary to pulmonary fibrosis. Given that endothelial cells are the main source of ET-1 and ET-1 from other cells may encounter difficulty penetrating vascular compartments, we hypothesize that endothelial-derived ET-1 promotes vascular remodeling secondary to pulmonary fibrosis. We used vascular endothelial ET-1 knock-out (VEETKO) and Wild type mice for this research. They were given intratracheal bleomycin and euthanized at day 28. We quantified pulmonary fibrosis, measured lung ET-1 and its receptors\u2019 expression, and assessed pulmonary vascular remodeling by calculating medial wall index, muscularization index, adventitial collagen and adventitial fibroblast and macrophage accumulation. Right ventricle remodeling was also assessed. Both VEETKO and Wild type mice developed comparable pulmonary fibrosis and similar fibrosis-related gene expression. Compared to Wild type mice, bleomycin-induced VEETKO mice had lower ET-1 peptide levels (15.4 pg\/mg vs. 31.2 pg\/mg, p&lt;0.01). Expression of both ET-1 receptors mRNAs were increased in fibrosis models. Bleomycin-induced fibrosis VEETKO mice had significantly less muscularized arterioles, lower muscularization index and attenuated adventitial collagen, fibroblast and macrophage accumulation as compared to that of Wild type mice. Right ventricular pressure, hypertrophy and fibrosis did not increase both in VEETKO and Wild type mice despite the more enhanced vascular remodeling in Wild type. In conclusion, endothelial-derived endothelin-1 promotes pulmonary vascular remodeling secondary to bleomycin-induced pulmonary fibrosis.<\/jats:p>","DOI":"10.33549\/physiolres.933812","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:00:20Z","timestamp":1567681220000},"page":"S185-S197","source":"Crossref","is-referenced-by-count":26,"title":["Endothelial-Derived Endothelin-1 Promotes Pulmonary Vascular Remodeling in Bleomycin-Induced Pulmonary Fibrosis"],"prefix":"10.33549","author":[{"given":"A. B.","family":"HARTOPO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"ARFIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"NAKAYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"YAGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"EMOTO","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2018,5,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"ARFIAN N, EMOTO N, VIGNON-ZELLWEGER N, NAKAYAMA K, YAGI K, HIRATA K: ET-1 deletion from endothelial cells protects the kidney during the extension phase of ischemia\/reperfusion injury. Biochem Biophys Res Commun 425: 443-449, 2012.","DOI":"10.1016\/j.bbrc.2012.07.121"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"BEHR J, RYU JH: Pulmonary hypertension in interstitial lung disease. Eur Respir J 31: 1357-1367, 2008.","DOI":"10.1183\/09031936.00171307"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"DAVIE N, HALEEN SJ, UPTON PD, POLAK JM, YACOUB MH, MORRELL NW, WHARTON J: ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165: 398-405, 2002.","DOI":"10.1164\/ajrccm.165.3.2104059"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"DE NUCCI G, THOMAS R, D'ORLEANS-JUSTE P, ANTUNES E, WALDER C, WARNER TD, VANE JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85: 9797-9800, 1988.","DOI":"10.1073\/pnas.85.24.9797"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"EBINA M, SHIMIZUKAWA M, SHIBATA N, KIMURA Y, SUZUKI T, ENDO M, SASANO H, KONDO T, NUKIWA T: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 169: 1203-1208, 2004.","DOI":"10.1164\/rccm.200308-1111oc"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"FARKAS L, FARKAS D, ASK K, MOLLER A, GAULDIE J, MARGETTS P, INMAN M, KOLB M: VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest 119: 1298-1311, 2009.","DOI":"10.1172\/jci36136"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"FARKAS L, GAULDIE J, VOELKEL NF, KOLB M: Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 45: 1-15, 2011.","DOI":"10.1165\/rcmb.2010-0365tr"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"FRID MG, BRUNETTI JA, BURKE DL, CARPENTER TC, DAVIE NJ, REEVES JT, ROEDERSHEIMER MT, VAN ROOIJEN N, STENMARK KR: Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage. Am J Pathol 168: 659-669, 2006.","DOI":"10.2353\/ajpath.2006.050599"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"GALIE N, MANES A, BRANZI A: The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237, 2004.","DOI":"10.1016\/j.cardiores.2003.11.026"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"GIAID A, POLAK JM, GAITONDE V, HAMID QA, MOSCOSO G, LEGON S, UWANOGHO D, RONCALLI M, SHINMI O, SAWAMURA T, KIMURA S, YANAGISAWA M, MASAKI T, SPRINGALL DR: Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am J Respir Cell Mol Biol 4: 50-58, 1991.","DOI":"10.1165\/ajrcmb\/4.1.50"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"GIAID A, YANAGISAWA M, LANGLEBEN D, MICHEL RP, LEVY R, SHENNIB H, KIMURA S, MASAKI T, DUGUID WP, STEWART DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739, 1993.","DOI":"10.1056\/nejm199306173282402"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"GUEMBE L, VILLARO AC: Immunohistochemical mapping of endothelin in the developing and adult mouse lung. J Histochem Cytochem 49: 1301-1309, 2001.","DOI":"10.1177\/002215540104901013"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"IVY D, MCMURTRY IF, YANAGISAWA M, GARIEPY CE, LE CRAS TD, GEBB SA, MORRIS KG, WISEMAN RC, ABMAN SH: Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L1040-L1048, 2001.","DOI":"10.1152\/ajplung.2001.280.5.l1040"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"KELLAND NF, BAGNALL AJ, MORECROFT I, GULLIVER-SLOAN FH, DEMPSIE Y, NILSEN M, YANAGISAWA M, MACLEAN MR, KOTELEVTSEV YV, WEBB DJ: Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia. J Vasc Res 47: 16-22, 2010.","DOI":"10.1159\/000231717"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"KISANUKI YY, EMOTO N, OHUCHI T, WIDYANTORO B, YAGI K, NAKAYAMA K, KEDZIERSKI RM, HAMMER RE, YANAGISAWA H, WILLIAMS SC, RICHARDSON JA, SUZUKI T, YANAGISAWA M: Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 56: 121-128, 2010.","DOI":"10.1161\/hypertensionaha.109.138701"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"KOMURO I, KURIHARA H, SUGIYAMA T, YOSHIZUMI M, TAKAKU F, YAZAKI Y: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249-252, 1988.","DOI":"10.1016\/0014-5793(88)80489-7"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"KOSANOVIC D, LUITEL H, DAHAL BK, CORNITESCU T, JANSSEN W, DANSER AH, GARRELDS IM, DE MEY JG, FAZZI G, SCHIFFERS P, IGLARZ M, FISCHLI W, GHOFRANI HA, WEISSMANN N, GRIMMINGER F, SEEGER W, REISS I, SCHERMULY RT: Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis. Eur Respir J 46: 1084-1094, 2015.","DOI":"10.1183\/09031936.00018215"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"LI M, RIDDLE SR, FRID MG, EL KASMI KC, MCKINSEY TA, SOKOL RJ, STRASSHEIM D, MEYRICK B, YEAGER ME, FLOCKTON AR, MCKEON BA, LEMON DD, HORN TR, ANWAR A, BARAJAS C, STENMARK KR: Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol 187: 2711-2722, 2011.","DOI":"10.4049\/jimmunol.1100479"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"MANITSOPOULOS N, NIKITOPOULOU I, MANIATIS NA, MAGKOU C, KOTANIDOU A, ORFANOS SE: Highly selective endothelin-1 receptor A inhibition prevents bleomycin-induced pulmonary inflammation and fibrosis in mice. Respiration 95: 122-136, 2018.","DOI":"10.1159\/000481201"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"MEOLI DF, WHITE RJ: Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1\/2 MAP kinase. Can J Physiol Pharmacol 88: 830-839, 2010.","DOI":"10.1139\/y10-059"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"NATHAN SD, PNOBLE PW, TUDER RM: Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175: 875-880, 2007.","DOI":"10.1164\/rccm.200608-1153cc"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"OZAKI M, KAWASHIMA S, YAMASHITA T, OHASHI Y, RIKITAKE Y, INOUE N, HIRATA KI, HAYASHI Y, ITOH H, YOKOYAMA M: Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension 37: 322-327, 2011.","DOI":"10.1161\/01.hyp.37.2.322"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"PARK SH, SALEH D, GIAID A, MICHEL RP: Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med 156: 600-608, 1997.","DOI":"10.1164\/ajrccm.156.2.9607123"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"RODRIGUEZ-VITA J, RUIZ-ORTEGA M, RUPEREZ M, ESTEBAN V, SANCHEZ-LOPEZ E, PLAZA JJ, EGIDO J: Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Circ Res 97: 125-134, 2005.","DOI":"10.1161\/01.res.0000174614.74469.83"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"SELMAN M, PARDO A: Alveolar epithelial cell disintegrity and subsequent activation: a key process in pulmonary fibrosis. Am J Respir Crit Care Med 186: 119-121, 2012.","DOI":"10.1164\/rccm.201206-0997ed"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"SHI-WEN X, DENTON CP, DASHWOOD MR, HOLMES AM, BOU-GHARIOS G, PEARSON JD, BLACK CM, ABRAHAM DJ: Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol 116: 417-425, 2001.","DOI":"10.1046\/j.1523-1747.2001.01256.x"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"SOMA S, TAKAHASHI H, MURAMATSU M, OKA M, FUKUCHI Y: Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 20: 620-630, 1999.","DOI":"10.1165\/ajrcmb.20.4.3356"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"STENMARK KR, DAVIE N, FRID M, GERASIMOVSKAYA E, DAS M: Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 21: 134-145, 2006.","DOI":"10.1152\/physiol.00053.2005"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"STRIETER RM, MEHRAD B: New mechanisms of pulmonary fibrosis. Chest 136: 1364-1370, 2009.","DOI":"10.1378\/chest.09-0510"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"TEN FREYHAUS H, DAGNELL M, LEUCHS M, VANTLER M, BERGHAUSEN EM, CAGLAYAN E, WEISSMANN N, DAHAL BK, SCHERMULY RT, OSTMAN A, KAPPERT K, ROSENKRANZ S: Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 183: 1092-1102, 2011.","DOI":"10.1164\/rccm.200911-1663oc"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"VAN HUNG T, EMOTO N, VIGNON-ZELLWEGER N, NAKAYAMA K, YAGI K, SUZUKI Y, HIRATA K: Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin. Life Sci 118: 313-328, 2014.","DOI":"10.1016\/j.lfs.2013.12.215"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:00:27Z","timestamp":1567681227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/67\/67_S185.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,6]]},"references-count":31,"URL":"https:\/\/doi.org\/10.33549\/physiolres.933812","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,6]]}}}